SREBP1 as a Potential Biomarker Promotes Cell Proliferation and Invasion in Thyroid Cancer
NCT04072731 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 140
Last updated 2019-08-28
Summary
In this study, the investigators detected the expression of SREBP1 in thyroid cancer tissues, explored the biological functions of SREBP1 in thyroid cancer cells.
Conditions
Interventions
- OTHER
-
pathologic
All the enrolled patients were treated with whole resection and diagnosed by the Pathology Department based on the pathological evidence.
Sponsors & Collaborators
-
People's Hospital of Zhengzhou University
lead OTHER
Principal Investigators
-
Zhi Li, Prof. · Central South University
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-01-16
- Primary Completion
- 2017-07-30
- Completion
- 2018-01-01
Countries
- China
Study Locations
More Related Trials
-
Role of NGS-based ThyroSeq Panel in Cancer Diagnosis in Thyroid Nodules
NCT02352766 ·Status: COMPLETED
-
Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City
NCT04085900 ·Status: RECRUITING
-
Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy
NCT00898430 ·Status: TERMINATED
-
Investigating Utility of ctDNA and Tumour Evolution in Advanced Thyroid Cancer
NCT05837260 ·Status: RECRUITING
-
MRI and Metabolomics Biomarkers for Uterine Malignancy
NCT02528864 ·Status: COMPLETED
-
Correlation Between Various Urinary Exosomal Protein Biomarkers and Pathological Manifestation in Thyroid Follicular Neoplasm: Early and Pre-operative Diagnosis of Follicular Thyroid Cancer
NCT05463107 ·Status: ACTIVE_NOT_RECRUITING
-
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Hepatobiliary Cancer Malignancies
NCT04835675 ·Status: COMPLETED
-
Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy
NCT05112627 ·Status: COMPLETED
-
Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301
NCT01487733 ·Status: COMPLETED
-
Study of Proteins in Head and Neck Cancer Cells
NCT00896948 ·Status: COMPLETED
-
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
NCT03871816 ·Status: COMPLETED
-
DNA Methylation Biomarkers and Metastasis of Gastric Carcinoma
NCT02159339 ·Status: COMPLETED
-
Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
NCT01119573 ·Status: UNKNOWN
-
Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors
NCT04526587 ·Status: RECRUITING
-
New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence
NCT05410028 ·Status: RECRUITING
-
Proteogenomics for Follicular Cell-derived Thyroid Cancer: Development of a Classification and Prognosis Prediction Model
NCT06969768 ·Status: COMPLETED
-
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
NCT00230308 ·Status: RECRUITING
-
Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC
NCT07076979 ·Status: RECRUITING
-
Retinoblastoma Biomarker Study
NCT00342797 ·Status: COMPLETED
-
Newer Therapeutic Targets in Head and Neck Cancers
NCT05382585 ·Status: RECRUITING
-
Oxidative Stress and Mitochondrial TERT in Papillary Thyroid Cancer.
NCT05752669 ·Status: COMPLETED
-
Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers
NCT00899769 ·Status: COMPLETED
-
Screening and Validation of Serum Protein Biomarkers for Early Diagnosis of Gastric Cancer
NCT07096752 ·Status: NOT_YET_RECRUITING
-
Cell-free DNA Methylation Markers for Cancer Screening
NCT03096938 ·Status: UNKNOWN ·Phase: NA
-
Genomic Predictors of Papillary Microcarcinoma Disease Progression
NCT02363595 ·Status: RECRUITING